Results 31 to 40 of about 1,296 (168)

Current conservative treatment of uterine fibroids. Ulipristal acetate and liver damage: contrived tragedy? [PDF]

open access: yesГинекология, 2018
Uterine fibroids are the most common pelvic tumor formation in women and the most common indication for hysterectomy. The effectiveness of long-term intermittent use of ulipristal acetate (UA) in patients with uterine myoma has been proven earlier.
A L Tikhomirov
doaj   +1 more source

Modern aspects of complex treatment of hysteromyoma

open access: yesЛечащий Врач, 2021
Possibilities of efficiency increase of treating patients of late reproductive age with hysteromyoma were studied. In pre-surgery preparation, selective modulators of receptors to progesterone, and ulipristal acetate were used.
L. V. Adamyan   +3 more
doaj  

Predoperacijsko zdravljenje miomov z ulipristal acetatom

open access: yesZdravniški Vestnik, 2019
Izhodišče: Miomi so najpogostejši benigni tumorji maternice. Približno petina do polovica žensk z miomi ima simptome oz. pri njih miomi hitro rastejo. Najpogosteje gre za podaljšane in/ali močne menstruacijske krvavitve, ki povzroče anemijo, dismenorejo,
Andrej Vogler, Mišo Rajić
doaj   +1 more source

Safety after extended repeated use of ulipristal acetate for uterine fibroids. [PDF]

open access: yesPLoS ONE, 2017
To assess long term safety of extended repeated 3-month courses of ulipristal acetate (UPA) 10 mg/day, for up to 8 courses, with focus on endometrial and laboratory safety parameters.This long-term, multi-center, open-label cohort, follow up study ...
Bart C J M Fauser   +10 more
doaj   +1 more source

The epidemiology and pathogenesis of uterine fibroids

open access: yesInternational Journal of Gynecology &Obstetrics, Volume 171, Issue 3, Page 1029-1045, December 2025.
Abstract Uterine fibroids, or leiomyomas, are the most common benign tumors of the female reproductive tract, ultimately affecting a majority of women worldwide, primarily during their reproductive years. While their origin appears genetic, manifesting in monoclonal tumors, diverse features and mechanisms contribute to their growth and further ...
Malcolm G. Munro   +2 more
wiley   +1 more source

Ulipristal Acetate Efficacy in a Patient with Symptomatic Fibroid and Concomitant Pulmonary Embolism

open access: yesCase Reports in Medicine, 2020
Ulipristal acetate (UPA) is an effective drug for the treatment of symptomatic uterine fibroids. The drug is highly effective in controlling bleeding control and in the recovery of anemia.
S. von Wunster   +3 more
doaj   +1 more source

The Concise Guide to PHARMACOLOGY 2025/26: Nuclear hormone receptors

open access: yesBritish Journal of Pharmacology, Volume 182, Issue S1, Page S242-S258, December 2025.
The Concise Guide to Pharmacology 2025/26 marks the seventh edition in this series of biennial publications in the British Journal of Pharmacology. Presented in landscape format, the guide provides a comparative overview of the pharmacology of drug target families. The concise nature of the Concise Guide refers to the style of presentation, being clear,
Stephen P. H. Alexander   +20 more
wiley   +1 more source

Uterine fibroid – new possibilities of nosotropic therapy

open access: yesГинекология, 2013
In this article are given the results of studies SMRP: ulipristal acetate in the treatment of uterine fibroids, ulipristal acetate (Esmya).
A L Tikhomirov
doaj  

Capturing Emergency Contraceptive Pill Use: Critical Reflections on Measurement and Reporting

open access: yesStudies in Family Planning, Volume 56, Issue 3, Page 470-481, September 2025.
Abstract Emergency contraceptive pills (ECP) are an essential and unique postcoital method of preventing pregnancy. Trends in supply data show that sales of ECP are increasing at faster rates globally than many other contraceptives. Yet nationally representative survey data suggest that ECP use has remained relatively static overtime, suggesting ...
Joe Strong   +3 more
wiley   +1 more source

Quality of life 1 year after uterine artery embolization vs hysterectomy for symptomatic adenomyosis (QUESTA study)

open access: yesActa Obstetricia et Gynecologica Scandinavica, Volume 104, Issue 8, Page 1558-1574, August 2025.
After 1 year, both uterine artery embolization (UAE) and hysterectomy significantly improved health‐related quality of life (HRQOL) for patients with symptomatic adenomyosis. Neither non‐inferiority nor inferiority could be established within the predefined margins. HRQOL after 1 year was comparable in all HRQOL domains after UAE vs. hysterectomy. Both
Lisa M. Trommelen   +40 more
wiley   +1 more source

Home - About - Disclaimer - Privacy